Clinical Trials Directory

Trials / Completed

CompletedNCT01981876

Study of Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital

Status
Completed
Phase
Study type
Observational
Enrollment
305 (actual)
Sponsor
Tenwek Hospital · Academic / Other
Sex
All
Age
20 Years – 79 Years
Healthy volunteers
Accepted

Summary

Esophageal squamous cell cancer (ESCC) is common in the developing world, and is the leading cancer diagnosis at Tenwek Hospital in southwestern Kenya. The investigators long-term goal is to understand the pathogenesis and risk factors for ESCC in Kenya, and to establish effective screening and prevention programs. The investigators hypothesize that asymptomatic esophageal squamous dysplasia (ESD) is common in their region, and the current protocol is designed to determine the prevalence of ESD in residents of southwestern Kenya.

Detailed description

The prevalence of esophageal squamous dysplasia will be determined after evaluating pathology reports from unstained lesions and normal biopsies after staining with Lugol's iodine.

Conditions

Timeline

Start date
2010-10-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2013-11-13
Last updated
2015-02-27

Locations

1 site across 1 country: Kenya

Source: ClinicalTrials.gov record NCT01981876. Inclusion in this directory is not an endorsement.